HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous alternariosis in an immunocompromised patient.

Abstract
A case of cutaneous alternariosis in a 68-year-old male farmer is presented. The patient had been treated with prednisone and azathioprine for thrombocytopenic purpura, and two months later he noted multiple ulcerated and slightly infiltrated granulomatous lesions on exposed areas. The diagnosis was confirmed by results of direct examination, culture of biopsy material, and histologic examination. A concurrent herpetic infection healed without sequelae. The protracted course of our patient's condition and a review of the literature suggest the tapering or stopping of steroids as the first step in the successful and permanent treatment of cutaneous alternariosis.
AuthorsG C Chaidemenos, O Mourellou, G Karakatsanis, T Koussidou, D Panagiotidou, E Kapetis
JournalCutis (Cutis) Vol. 56 Issue 3 Pg. 145-50 (Sep 1995) ISSN: 0011-4162 [Print] United States
PMID8565598 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antimetabolites
  • Immunosuppressive Agents
  • Steroids
  • Azathioprine
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Aged
  • Alternaria (isolation & purification)
  • Antimetabolites (therapeutic use)
  • Azathioprine (adverse effects)
  • Biopsy
  • Child
  • Dermatomycoses (diagnosis, drug therapy, immunology, physiopathology)
  • Female
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents (adverse effects)
  • Male
  • Purpura, Thrombocytopenic (drug therapy)
  • Skin (pathology)
  • Steroids (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: